Allen & Overy files amicus brief in support of disability rights in reproductive healthcare
Related people
Headlines in this article
Related news and insights
Publications: 05 April 2024
National Security Division Announces New Self-Disclosure Policy in M&A Transactions
News: 04 April 2024
Publications: 12 March 2024
Publications: 06 March 2024
Shifting Strategies in U.S. Intellectual Property Disputes: Lessons from 2023
The brief supports the FDA’s brief and advocates in favor of sustaining regulatory actions that have eased access to mifepristone. The brief focuses on the barriers individuals with disabilities face in accessing healthcare that would only be exacerbated by reinstating outdated and medically unnecessary restrictions to medication abortion. The brief emphasizes that imposing such restrictions do not “protect the health or safety of people with disabilities—instead, it disproportionately robs them of accessible health care options that preserve their bodily autonomy and privacy and may even put their health and lives at risk.”
The A&O team included associates Elizabeth June and Megan Ines.